Prostate cancer organoids pave way towards precision oncology
Scientists develop organoid models of neuroendocrine prostate cancer to study EZH2 inhibitors and reveal a potential new target. Researchers at... Read More
Scientists develop organoid models of neuroendocrine prostate cancer to study EZH2 inhibitors and reveal a potential new target. Researchers at... Read More
My name is Bruce Mylrea. I am 62 and I was diagnosed with advanced prostate cancer exactly nine years ago... Read More